Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out

被引：0
|
作者：
Alexandre R Zlotta
Claude Schulman
机构：
[1] Senior Faculty in Urology at the University Clinics of Brussels in Brussels,Chief of the Department of Urology at Erasme Hospital
[2] University Clinics of Brussels,undefined
[3] and a Professor of Urology at the University of Brussels,undefined
来源：
Nature Clinical Practice Urology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：474 / 475
页数：1
相关论文
共 50 条
  • [1] Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out
    Zlotta, Alexandre R.
    Schulman, Claude
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (09): : 474 - 475
  • [2] Immediate versus deferred androgen-deprivation therapy for localized prostate cancer
    Nature Clinical Practice Urology, 2006, 3 (7): : 348 - 349
  • [3] Timing of androgen-deprivation therapy in prostate cancer
    Nandagopal, Lakshminarayanan
    LANCET ONCOLOGY, 2017, 18 (11): : E634 - E634
  • [4] Is there still a role for bilateral orchidectomy in androgen-deprivation therapy for metastatic prostate cancer?
    Atta, Mohamed Adel
    Elabbady, Ahmed
    Sameh, Wael
    Sharafeldeen, Mohamed
    Elsaqa, Mohamed
    ARAB JOURNAL OF UROLOGY, 2020, 18 (01) : 9 - 13
  • [5] Insomnia and androgen-deprivation therapy for prostate cancer
    Savard, J.
    Ivers, H.
    Simard, S.
    PSYCHO-ONCOLOGY, 2007, 16 (09) : S150 - S151
  • [6] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
    Jin, C.
    Fan, Y.
    Meng, Y.
    Shen, C.
    Wang, Y.
    Hu, S.
    Cui, C.
    Xu, T.
    Yu, W.
    Jin, J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (04) : 333 - 339
  • [7] Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse
    Garcia-Albeniz, Xabier
    Chan, June M.
    Paciorek, Alan T.
    Logan, Roger W.
    Kenfield, Stacey A.
    Cooperberg, Matthew R.
    Caroll, Peter
    Hernan, Miguel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
    C Jin
    Y Fan
    Y Meng
    C Shen
    Y Wang
    S Hu
    C Cui
    T Xu
    W Yu
    J Jin
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 333 - 339
  • [9] Timing of androgen-deprivation therapy for prostate cancer: still a long way to go Reply
    Duchesne, Gillian M.
    LANCET ONCOLOGY, 2016, 17 (08): : E313 - E314
  • [10] Biopsychosocial impact of prostate cancer and androgen-deprivation therapy
    Tripp, Dean A.
    Verreault, Phylicia
    Tong, Steven
    Izard, Jason
    Black, Angela
    Siemens, D. Robert
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (10): : 338 - 343
12345